Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05626478 · ClinicalTrials.gov registry record · Phase 4
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
A Phase 4 study, sponsored by Nicole Fram M.D..
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT05626478: Completed Phase 4 study, sponsored by Nicole Fram M.D..
NCT05626478 is a Phase 4 study that has completed, run by Nicole Fram M.D.. The registered enrollment target is 50 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05626478, a Phase 4 study, has completed, sponsored by Nicole Fram M.D..
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
Primary Outcome
Measured by SUN (Standardization on Uveitis Nomenclature) grading scale: absence of cell to be defined as a grade of 0-0.5 and absence of flare to be defined as a grade of: 0-1. 0-4 score scale, higher scores mean a worse outcome. 0-1 Absent, 1-2 Mild, 2-3 Moderate, 4 Severe.
Interventions
- DRUG Prednisolone Acetate 1% Oph Susp
- DRUG Dextenza 0.4Mg Ophthalmic Insert
- DRUG Prolensa 0.07% Ophthalmic Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2025-02-05 |
| Phase | Phase 4 |
What the finished NCT05626478 record still lists
NCT05626478 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 3 interventions - of which Prednisolone Acetate 1% Oph Susp is the first listed.
NCT05626478 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05626478 about?
NCT05626478 is a clinical study titled "Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery". Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
What is the current status of trial NCT05626478?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2023-06-01. Estimated completion is 2025-02-05.
What interventions are being tested in trial NCT05626478?
The interventions under investigation include: Prednisolone Acetate 1% Oph Susp (DRUG), Dextenza 0.4Mg Ophthalmic Insert (DRUG), Prolensa 0.07% Ophthalmic Solution (DRUG).
Who is sponsoring clinical trial NCT05626478?
This trial is sponsored by Nicole Fram M.D., which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05626478's enrollment target sits among peer trials
50 1255th of 2000 higher than 678 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI